Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 14, 2011

Primary Completion Date

April 24, 2018

Study Completion Date

April 24, 2019

Conditions
H5N1 Influenza
Interventions
BIOLOGICAL

Ad4-H5-VTN vaccination-tonsillar route

BIOLOGICAL

Ad4-H5-vaccination-oral route

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01443936 - Experimental AD4-H5-VTN Vaccine in Healthy Volunteers | Biotech Hunter | Biotech Hunter